These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28688278)

  • 21. Discovery of Novel Macrocyclic Hedgehog Pathway Inhibitors Acting by Suppressing the Gli-Mediated Transcription.
    Liu G; Huang W; Wang J; Liu X; Yang J; Zhang Y; Geng Y; Tan W; Zhang A
    J Med Chem; 2017 Oct; 60(19):8218-8245. PubMed ID: 28873303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth.
    Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W
    BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of taladegib as a sonic hedgehog signaling pathway inhibitor.
    Jin G; Sivaraman A; Lee K
    Arch Pharm Res; 2017 Dec; 40(12):1390-1393. PubMed ID: 29159582
    [No Abstract]   [Full Text] [Related]  

  • 25. Discovery of novel 4-(2-pyrimidinylamino)benzamide derivatives as highly potent and orally available hedgehog signaling pathway inhibitors.
    Xin M; Zhang L; Jin Q; Tang F; Wen J; Gu L; Cheng L; Zhao Y
    Eur J Med Chem; 2016 Mar; 110():115-25. PubMed ID: 26820554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors.
    Liu Z; Wang R; Guo R; Hu J; Li R; Zhao Y; Gong P
    Bioorg Med Chem; 2014 Jul; 22(14):3642-53. PubMed ID: 24882675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.
    Zhang S; Zhao Y; Liu Y; Chen D; Lan W; Zhao Q; Dong C; Xia L; Gong P
    Eur J Med Chem; 2010 Aug; 45(8):3504-10. PubMed ID: 20537434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and antitumor activity of phthalazine-1,4-dione-based menaquinone analogs.
    Fujii S; Miura T; Oikawa T; Qin XY; Kojima S; Kagechika H
    Bioorg Med Chem Lett; 2021 Jul; 43():128065. PubMed ID: 33915257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition.
    Elmeligie S; Aboul-Magd AM; Lasheen DS; Ibrahim TM; Abdelghany TM; Khojah SM; Abouzid KAM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1347-1367. PubMed ID: 31322015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.
    Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ
    Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and pharmacological evaluation of trifluoromethyl containing 4-(2-pyrimidinylamino)benzamides as Hedgehog signaling pathway inhibitors.
    Xin M; Zhang L; Wen J; Shen H; Liu Z; Zhao X; Jin Q; Wang M; Cheng L; Huang W; Tang F
    Bioorg Med Chem; 2016 Mar; 24(5):1079-88. PubMed ID: 26827136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity.
    Arai MA; Utsumi T; Yanase N; Fujimatsu T; Ishibashi M
    Chem Pharm Bull (Tokyo); 2017; 65(8):784-795. PubMed ID: 28768932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors.
    Xin M; Wen J; Tang F; Tu C; Shen H; Zhao X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6777-83. PubMed ID: 24176396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
    Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
    J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and evaluation of pyrrolo[2,1-f][1,2,4]triazine derivatives as novel hedgehog signaling pathway inhibitors.
    Xin M; Zhang L; Tang F; Tu C; Wen J; Zhao X; Liu Z; Cheng L; Shen H
    Bioorg Med Chem; 2014 Feb; 22(4):1429-40. PubMed ID: 24486203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of new phthalazine-based derivatives as potential EGFR inhibitors for the treatment of hepatocellular carcinoma.
    Boraei ATA; Ashour HK; El Tamany ESH; Abdelmoaty N; El-Falouji AI; Gomaa MS
    Bioorg Chem; 2019 Apr; 85():293-307. PubMed ID: 30654221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel indole derivative, 2-{3-[1-(benzylsulfonyl)piperidin-4-yl]-2-methyl-1H-indol-1-yl}-1-(pyrrolidin-1-yl)ethenone, suppresses hedgehog signaling and drug-resistant tumor growth.
    Jung JH; Lee H; Jeon J; Lee YJ; Nada H; Kim M; Lee H; Bhattarai D; Lee K; Ko HW
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400218. PubMed ID: 38963677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines.
    Kaizerman JA; Aaron W; An S; Austin R; Brown M; Chong A; Huang T; Hungate R; Jiang B; Johnson MG; Lee G; Lucas BS; Orf J; Rong M; Toteva MM; Wickramasinghe D; Xu G; Ye Q; Zhong W; McMinn DL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4607-10. PubMed ID: 20594845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
    Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
    J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
    Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S
    Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.